Urgent statement on antithrombotic therapy of atrial fibrillation.
نویسندگان
چکیده
Disturbed-Flow-Mediated Vascular Reactive Oxygen Species Induce Endothelial Dysfunction Kyung-Sun Heo, Keigi Fujiwara, Jun-ichi Abe ····································2722 Current Status and Trends in the Treatment of Acute Pulmonary Thromboembolism Norikazu Yamada, Mashio Nakamura, Masaaki Ito ····································2731 Chronic Inflammation Links Cardiovascular, Metabolic and Renal Diseases (2010 Sato Award) Ichiro Manabe ····································2739
منابع مشابه
Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke
Catheter ablation therapy for atrial fibrillation (AF) is a safe and effective treatment for patients with both paroxysmal and persistent symptomatic AF. However, given the uncertainty about recurrence after the ablation procedure and continued risk of thromboembolism, it is still recommended to treat with anticoagulation for the long-term prevention of stroke. Left atrial appendage (LAA) occlu...
متن کاملManagement of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This cons...
متن کاملClinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation
The past year has seen the publication of results of the largest and arguably the most significant clinical trials of antithrombotic to prevent stroke and systemic thromboembolism in patients with atrial fibrillation (AF) (1-3). In 2011, results of two trials concerning anticoagulation in patients with AF in addition to RE-LY study were also published (4-6). Canadian AF guidelines has been upda...
متن کاملAntithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis and the risk of bleeding. The full c...
متن کاملChoosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.
OBJECTIVE To determine whether the risk of falling (with a possible increased chance of subdural hematoma) should influence the choice of antithrombotic therapy in elderly patients with atrial fibrillation. DESIGN A Markov decision analytic model was used to determine the preferred treatment strategy (no antithrombotic therapy, long-term aspirin use, or long-term warfarin use) for patients wi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation journal : official journal of the Japanese Circulation Society
دوره 75 12 شماره
صفحات -
تاریخ انتشار 2011